Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

ZSP1273

Aliases
zsp1273 granules, ZSP1273 tablet

8 clinical trials

9 indications

Indication
bioequivalence
Indication
Kidney Impairment
Indication
Drug-drug interactions
Indication
pharmacokinetics
Indication
Influenza A
Indication
Elder
Indication
Warfarin
Indication
Midazolam
Indication
Liver Impairment
Clinical trial
Single-dose, Open-label, Randomized, Crossover Bioavailability Study of 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 Under Fasted Condition in Healthy Participants
Status: Completed, Estimated PCD: 2023-12-15
Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Severe Kidney Impairment on the Pharmacokinetics, Safety and Tolerability of ZSP1273
Status: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
A Open-Label, Two-sequence Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid in Healthy Participants
Status: Completed, Estimated PCD: 2023-11-20
Clinical trial
Single-center, Open-label, Non-randomized and Single-dose Clinical Trial to Explore the Mass Balance of Oral Suspension of 600mg [14C]ZSP1273
Status: Completed, Estimated PCD: 2023-04-28
Clinical trial
A Randomized, Double-blind Phase III Clinical Study of ZSP1273 Tablets Compared With Placebo or Oseltamivir Patients With Acute Uncomplicated Influenza A
Status: Completed, Estimated PCD: 2023-04-01
Clinical trial
A Phase 1, Open-Label, Two-Period，Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
Status: Completed, Estimated PCD: 2023-07-21
Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate Pharmacokinetics, Safety and Tolerability of ZSP1273 in Elder Participants
Status: Completed, Estimated PCD: 2023-11-01
Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ZSP1273
Status: Completed, Estimated PCD: 2023-07-04